An Act to repeal 632.865 (2) and 632.865 (5) (e); to renumber 632.865 (4); to amend 40.51 (8), 40.51 (8m), 66.0137 (4), 120.13 (2) (g), 185.983 (1) (intro.), 609.83, 632.861 (4) (a), 632.865 (1) (ae) and 632.865 (6) (c) 3.; to create 632.861 (1m), 632.861 (3g), 632.861 (3r), 632.861 (4) (e), 632.862, 632.865 (1) (ab) and (ac), 632.865 (1) (an), (aq) and (at), 632.865 (1) (bm), 632.865 (1) (cg) and (cr), 632.865 (2d), 632.865 (2h), 632.865 (2p), 632.865 (2t), 632.865 (4) (b), 632.865 (4m), 632.865 (5d), 632.865 (5h), 632.865 (5p), 632.865 (5t), 632.865 (6) (bm), 632.865 (6) (c) 3m., 632.865 (6g), 632.865 (6r) and 632.865 (8) of the statutes; Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
| Date / House | Action | Journal |
|---|---|---|
| 4/16/2025 Sen. | Introduced by Senators Felzkowski, Marklein, Cabral-Guevara, Dassler-Alfheim, Drake, Habush Sinykin, L. Johnson, Keyeski, Larson, Nass, Pfaff, Quinn, Ratcliff, Roys, Spreitzer, Wanggaard, Wimberger and James; cosponsored by Representatives Novak, Tranel, Allen, Armstrong, Brooks, Callahan, Fitzgerald, B. Jacobson, Joers, Kirsch, Kitchens, Knodl, Kreibich, McCarville, Miresse, Mursau, O'Connor, Rodriguez, Sortwell, Tittl, Wichgers and Tucker | |
| 4/16/2025 Sen. | Read first time and referred to Committee on Health |
